Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

ClinicalTrials.gov ID: NCT00138671

Public ClinicalTrials.gov record NCT00138671. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Chronic Obstructive Pulmonary Disease.

Study identification

NCT ID
NCT00138671
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
105 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2003 (Type not available)
Primary completion
Sep 2008 (Actual)
Completion
Sep 2008 (Actual)
Last update posted
Feb 2, 2010

2003 – 2008

United States locations

U.S. sites
77
U.S. states
31
U.S. cities
62
Facility City State ZIP Site status
Pfizer Investigational Site Glendale Arizona 85306 —
Pfizer Investigational Site Peoria Arizona 85381 —
Pfizer Investigational Site Phoenix Arizona 85004 —
Pfizer Investigational Site Phoenix Arizona 85006 —
Pfizer Investigational Site Phoenix Arizona 85016 —
Pfizer Investigational Site Tucson Arizona 85715 —
Pfizer Investigational Site Jonesboro Arkansas 72401 —
Pfizer Investigational Site Searcy Arkansas 72143 —
Pfizer Investigational Site Berkeley California 94705 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site Greenbrae California 94904 —
Pfizer Investigational Site Huntington Beach California 92648 —
Pfizer Investigational Site Los Angeles California 90073 —
Pfizer Investigational Site Riverside California 92506 —
Pfizer Investigational Site Tustin California 92780 —
Pfizer Investigational Site Denver Colorado 80209 —
Pfizer Investigational Site Waterbury Connecticut 06708 —
Pfizer Investigational Site Chiefland Florida 32626 —
Pfizer Investigational Site Clearwater Florida 33756 —
Pfizer Investigational Site Clearwater Florida 33765 —
Pfizer Investigational Site DeLand Florida 32720 —
Pfizer Investigational Site Gainesville Florida 32608 —
Pfizer Investigational Site Lake City Florida 32025 —
Pfizer Investigational Site Melbourne Florida 32901 —
Pfizer Investigational Site Miami Florida 33144 —
Pfizer Investigational Site West Palm Beach Florida 33401 —
Pfizer Investigational Site Winter Park Florida 32789 —
Pfizer Investigational Site Decatur Georgia 30033 —
Pfizer Investigational Site Honolulu Hawaii 96813 —
Pfizer Investigational Site Honululu Hawaii 96814 —
Pfizer Investigational Site Chicago Illinois 60607 —
Pfizer Investigational Site Normal Illinois 61761 —
Pfizer Investigational Site Evansville Indiana 47713-1227 —
Pfizer Investigational Site Indianapolis Indiana 46250 —
Pfizer Investigational Site Des Moines Iowa 50314 —
Pfizer Investigational Site Wichita Kansas 67203 —
Pfizer Investigational Site Madisonville Kentucky 42431 —
Pfizer Investigational Site New Orleans Louisiana 70119 —
Pfizer Investigational Site Springfield Massachusetts 01103 —
Pfizer Investigational Site Springfield Massachusetts 01107 —
Pfizer Investigational Site Waltham Massachusetts 02453 —
Pfizer Investigational Site Kansas City Missouri 64106 —
Pfizer Investigational Site St Louis Missouri 63141 —
Pfizer Investigational Site Butte Montana 59701 —
Pfizer Investigational Site Omaha Nebraska 68105 —
Pfizer Investigational Site Henderson Nevada 89015 —
Pfizer Investigational Site Las Vegas Nevada 89103 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Albany New York 12205 —
Pfizer Investigational Site Albany New York 12206 —
Pfizer Investigational Site Cincinnati Ohio 45231 —
Pfizer Investigational Site Cincinnati Ohio 45242 —
Pfizer Investigational Site Toledo Ohio 43608 —
Pfizer Investigational Site Oklahoma City Oklahoma 73103 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Portland Oregon 97219 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15243 —
Pfizer Investigational Site Spartanburg South Carolina 29303 —
Pfizer Investigational Site Spartanburg South Carolina 29307 —
Pfizer Investigational Site Memphis Tennessee 38119 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Beaumont Texas 77706 —
Pfizer Investigational Site Dallas Texas 75231 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site San Antonio Texas 78237 —
Pfizer Investigational Site Fredericksburg Virginia 22401 —
Pfizer Investigational Site Fredericksburg Virginia 22408 —
Pfizer Investigational Site Richmond Virginia 23225 —
Pfizer Investigational Site Richmond Virginia 23229 —
Pfizer Investigational Site Richmond Virginia 23235 —
Pfizer Investigational Site Richmond Virginia 23249 —
Pfizer Investigational Site Spokane Washington 99202 —
Pfizer Investigational Site Spokane Washington 99204 —
Pfizer Investigational Site Huntington West Virginia 25701 —
Pfizer Investigational Site Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00138671, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2010 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00138671 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →